​

Funding Round

Series A - Aktis Oncology

Series A - Aktis Oncology

Investment Firm

Overview

Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.

Announced Date

Aug 25, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

N/A

Investor Lead

N/A

Participant Investors

12

Investor Name
Participant InvestorMerck
Participant InvestorTCG Crossover
Participant InvestorMPM Capital
Participant InvestorBristol-Myers Squibb
Participant InvestorNovartis

Round Details and Background

Aktis Oncology raised $84000000 on 2022-08-25 in Series A

Aktis Oncology is a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 18, 2021
Series A - Aktis Oncology
7-72.0M
Aug 25, 2022
Series A - Aktis Oncology
14-84.0M
May 21, 2024
Corporate Round - Aktis Oncology
1-undefined

Recent Activity

There is no recent news or activity for this profile.